Priftin

Priftin is a brand name of rifapentine, approved by the FDA in the following formulation(s):

PRIFTIN (rifapentine - tablet; oral)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: June 22, 1998
  
  Strength(s): 150MG ^[RLD]

Has a generic version of Priftin been approved?

No. There is currently no therapeutically equivalent version of Priftin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Priftin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Priftin.

See also...

• Priftin Consumer Information (Wolters Kluwer)
• Priftin Consumer Information (Cerner Multum)
• Priftin Advanced Consumer Information (Micromedex)
• Priftin AHFS DI Monographs (ASHP)
• Rifapentine Consumer Information (Wolters Kluwer)
• Rifapentine Consumer Information (Cerner Multum)
• Rifapentine Advanced Consumer Information (Micromedex)
• Rifapentine AHFS DI Monographs (ASHP)